Moreover, the classical major risk of stimulation OS—ovarian hyperstimulation syndrome—has now been practically eradicated by the possibility of triggering ovulation with an agonist of GnRH [54]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.